ATE216361T1 - Vitamin d derivate - Google Patents

Vitamin d derivate

Info

Publication number: ATE216361T1
Authority: AT; Austria
Prior art keywords: hydrogen; methylene; substituted; optionally; formula
Prior art date: 1996-10-30

Application number

AT97910261T

Other languages

English (en)

Inventor

Martin John Galverley

Henrik Pedersen

Original Assignee

Leo Pharm Prod Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-30

Filing date

1997-10-27

Publication date

2002-05-15

1997-10-27 Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216361T1 publication Critical patent/ATE216361T1/de

Links

150000003710 vitamin D derivatives Chemical class 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical group C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
230000004069 differentiation Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
125000000743 hydrocarbylene group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000002519 immonomodulatory effect Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Steroid Compounds (AREA)

AT97910261T 1996-10-30 1997-10-27 Vitamin d derivate ATE216361T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9622590.9A GB9622590D0 (en)	1996-10-30	1996-10-30	Chemical compounds
PCT/DK1997/000472 WO1998018759A1 (en)	1996-10-30	1997-10-27	Vitamin d analogues

Publications (1)

Publication Number	Publication Date
ATE216361T1 true ATE216361T1 (de)	2002-05-15

Family

ID=10802170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97910261T ATE216361T1 (de)	1996-10-30	1997-10-27	Vitamin d derivate

Country Status (20)

Country	Link
US (1)	US6310226B1 (de)
EP (1)	EP0937038B1 (de)
JP (1)	JP3907010B2 (de)
KR (1)	KR100526644B1 (de)
CN (1)	CN1107669C (de)
AT (1)	ATE216361T1 (de)
AU (1)	AU722659B2 (de)
CA (1)	CA2266479C (de)
CZ (1)	CZ290933B6 (de)
DE (1)	DE69712086T2 (de)
DK (1)	DK0937038T3 (de)
ES (1)	ES2173425T3 (de)
GB (1)	GB9622590D0 (de)
HU (1)	HUP9904333A3 (de)
NZ (1)	NZ334328A (de)
PL (1)	PL192660B1 (de)
PT (1)	PT937038E (de)
RO (1)	RO120338B1 (de)
RU (1)	RU2183622C2 (de)
WO (1)	WO1998018759A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001510183A (ja) *	1997-07-17	2001-07-31	エフ．ホフマン−ラロシュアーゲー	側鎖に２つの不飽和結合を有するジホモ−セコ−コレスタン
US7351869B2 (en) *	2002-11-18	2008-04-01	Teva Pharmaceutical Industries Ltd	Crystallization method for purification of calcipotriene
ATE390411T1 (de) *	2004-03-18	2008-04-15	Leo Pharma As	Stereoselektive synthese von vitamin-d-analoga
CA2586679A1 (en)	2004-11-12	2006-05-18	Bioxell Spa	Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
WO2006113990A2 (en) *	2005-04-25	2006-11-02	Cytochroma Inc.	LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
US20080051375A1 (en) *	2006-08-25	2008-02-28	Auerbach Alan H	Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
EP2425874A3 (de)	2006-08-25	2013-05-15	Cougar Biotechnology, Inc.	Verwendung von einer Vitamin D Verbindung und eines zusätzlichen therapeutischen Mittel in der Behandlung von Krebs
US20080064669A1 (en) *	2006-08-29	2008-03-13	Rakefet Cohen	Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility
CA2981549A1 (en)	2009-01-27	2010-08-05	Berg Llc	Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
WO2011002756A2 (en) *	2009-07-01	2011-01-06	Vitamin Derivatives, Inc.	Vitamin d compounds and methods for preparing same
CN106265695B (zh)	2009-08-14	2021-05-07	博格有限责任公司	用于治疗脱发的维生素d3及其类似物
CN112156097A (zh)	2013-05-29	2021-01-01	博格有限责任公司	使用维生素d预防或减轻化疗诱发的脱发
UA124972C2 (uk)	2016-07-29	2021-12-22	Янссен Фармацевтика Нв	Способи лікування раку передміхурової залози

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8914963D0 (en) *	1989-06-29	1989-08-23	Leo Pharm Prod Ltd	Chemical compounds
US5260290A (en) *	1990-02-14	1993-11-09	Wisconsin Alumni Research Foundation	Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
GB9017890D0 (en) *	1990-08-15	1990-09-26	Leo Pharm Prod Ltd	Chemical compounds i
GB9206648D0 (en) *	1992-03-26	1992-05-06	Leo Pharm Prod Ltd	Chemical compounds
GB9223061D0 (en) *	1992-11-04	1992-12-16	Leo Pharm Prod Ltd	Chemical compounds
US5449668A (en)	1993-06-04	1995-09-12	Duphar International Research B.V.	Vitamin D compounds and method of preparing these compounds
US5552392A (en) *	1993-11-03	1996-09-03	Wisconsin Alumni Research Foundation	Method of treating hypoparathyroidism with (20S) vitamin D compounds
JP3228488B2 (ja)	1993-12-24	2001-11-12	株式会社クラレ	２０−エピステロイド誘導体およびその製造方法
JPH0888281A (ja) *	1994-09-19	1996-04-02	Fujitsu Ltd	半導体装置
CA2175881A1 (en) *	1995-05-09	1996-11-10	Andrzej Kutner	Vitamin d compounds and methods of preparing these compounds

1996
- 1996-10-30 GB GBGB9622590.9A patent/GB9622590D0/en active Pending
1997
- 1997-10-27 ES ES97910261T patent/ES2173425T3/es not_active Expired - Lifetime
- 1997-10-27 US US09/297,387 patent/US6310226B1/en not_active Expired - Lifetime
- 1997-10-27 RO RO99-00325A patent/RO120338B1/ro unknown
- 1997-10-27 HU HU9904333A patent/HUP9904333A3/hu unknown
- 1997-10-27 JP JP51993198A patent/JP3907010B2/ja not_active Expired - Lifetime
- 1997-10-27 KR KR10-1999-7002315A patent/KR100526644B1/ko not_active Expired - Lifetime
- 1997-10-27 CN CN97198407A patent/CN1107669C/zh not_active Expired - Lifetime
- 1997-10-27 DK DK97910261T patent/DK0937038T3/da active
- 1997-10-27 CA CA002266479A patent/CA2266479C/en not_active Expired - Lifetime
- 1997-10-27 RU RU99111777/04A patent/RU2183622C2/ru active
- 1997-10-27 WO PCT/DK1997/000472 patent/WO1998018759A1/en not_active Ceased
- 1997-10-27 NZ NZ334328A patent/NZ334328A/xx not_active IP Right Cessation
- 1997-10-27 DE DE69712086T patent/DE69712086T2/de not_active Expired - Lifetime
- 1997-10-27 AT AT97910261T patent/ATE216361T1/de active
- 1997-10-27 EP EP97910261A patent/EP0937038B1/de not_active Expired - Lifetime
- 1997-10-27 PL PL333068A patent/PL192660B1/pl unknown
- 1997-10-27 CZ CZ19991358A patent/CZ290933B6/cs not_active IP Right Cessation
- 1997-10-27 PT PT97910261T patent/PT937038E/pt unknown
- 1997-10-27 AU AU47717/97A patent/AU722659B2/en not_active Expired

Also Published As

Publication number	Publication date
CZ290933B6 (cs)	2002-11-13
EP0937038A1 (de)	1999-08-25
CA2266479A1 (en)	1998-05-07
RU2183622C2 (ru)	2002-06-20
PT937038E (pt)	2002-09-30
KR20000036233A (ko)	2000-06-26
AU722659B2 (en)	2000-08-10
KR100526644B1 (ko)	2005-11-08
CZ135899A3 (cs)	1999-07-14
WO1998018759A1 (en)	1998-05-07
ES2173425T3 (es)	2002-10-16
CN1232448A (zh)	1999-10-20
AU4771797A (en)	1998-05-22
JP3907010B2 (ja)	2007-04-18
DK0937038T3 (da)	2002-07-15
JP2001503403A (ja)	2001-03-13
NZ334328A (en)	2000-09-29
GB9622590D0 (en)	1997-01-08
CN1107669C (zh)	2003-05-07
RO120338B1 (ro)	2005-12-30
PL333068A1 (en)	1999-11-08
US6310226B1 (en)	2001-10-30
CA2266479C (en)	2008-09-23
HUP9904333A2 (hu)	2000-06-28
EP0937038B1 (de)	2002-04-17
DE69712086T2 (de)	2002-11-14
HK1022298A1 (en)	2000-08-04
HUP9904333A3 (en)	2001-06-28
PL192660B1 (pl)	2006-11-30
DE69712086D1 (de)	2002-05-23

Legal Events

Date	Code	Title	Description
2002-10-15	UEP	Publication of translation of european patent specification

Publication	Publication Date	Title
EP0648207A1 (de)	1995-04-19	Vitamin d derivate.
ATE216361T1 (de)	2002-05-15	Vitamin d derivate
FI956108A0 (fi)	1995-12-19	Uudet D-vitamiinianalogit
EP0633878A1 (de)	1995-01-18	Neue vitamin-d analoge.
NZ332237A (en)	2000-07-28	Vitamin D analogues
DK0865428T3 (da)	2000-09-25	Nye vitamin D analoger
EP0662954A1 (de)	1995-07-19	Neuen vitamin d derivate.
EP0662953A1 (de)	1995-07-19	Neue vitamin d derivate.
PT944592E (pt)	2005-04-29	Derivados de vitamina d3
SE8803143D0 (sv)	1988-09-07	Alternativa energisubstrat
CA2222785A1 (en)	1997-06-12	Vitamin d analogues